Bpifrance SA - Q3 2020 holdings

$349 Million is the total value of Bpifrance SA's 6 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 42.9% .

 Value Shares↓ Weighting
FTI  TECHNIPFMC PLC$157,940,000
-6.7%
24,688,6910.0%45.29%
+8.4%
CSTM  CONSTELLIUM NVcl a$128,692,000
+2.2%
16,393,9030.0%36.91%
+18.8%
CRTO  CRITEO S Aspons ads$33,142,000
+7.0%
2,718,7520.0%9.50%
+24.4%
SQNS SellSEQUANS COMMUNICATIONS S Aspons ads$20,172,000
-4.8%
3,378,963
-2.1%
5.78%
+10.7%
CLLS NewCELLECTISspons ads$7,876,000425,726
+100.0%
2.26%
MLND SellMILLENDO THERAPEUTICS INC$875,000
-53.9%
536,805
-50.2%
0.25%
-46.4%
CRNX ExitCRINETICS PHARMACEUTICALS$0-12,418
-100.0%
-0.05%
TLND ExitTALEND S Aads$0-1,612,895
-100.0%
-13.79%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15

View Bpifrance SA's complete filings history.

Compare quarters

Export Bpifrance SA's holdings